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Background: The geographic distribution of canine infection with vector-borne disease agents in the United States
appears to be expanding.
Methods: To provide an updated assessment of geographic trends in canine infection with Dirofilaria immitis,
Borrelia burgdorferi, Ehrlichia spp., and Anaplasma spp., we evaluated results from an average of 3,588,477 dogs
tested annually by veterinarians throughout the United States from 2010 – 2012.
Results: As in an earlier summary report, the percent positive test results varied by agent and region, with antigen of
D. immitis and antibody to Ehrlichia spp. most commonly identified in the Southeast (2.9% and 3.2%, respectively) and
antibody to both B. burgdorferi and Anaplasma spp. most commonly identified in the Northeast (13.3% and 7.1%,
respectively) and upper Midwest (4.4% and 3.9%, respectively). Percent positive test results for D. immitis antigen were
lower in every region considered, including in the Southeast, than previously reported. Percent positive test results for
antibodies to B. burgdorferi and Ehrlichia spp. were higher nationally than previously reported, and, for antibodies to
Anaplasma spp., were higher in the Northeast but lower in the Midwest and West, than in the initial report. Annual
reports of human cases of Lyme disease, ehrlichiosis, and anaplasmosis were associated with percent positive canine test
results by state for each respective tick-borne disease agent (R2 = 0.701, 0.457, and 0.314, respectively). Within endemic
areas, percent positive test results for all three tick-borne agents demonstrated evidence of geographic expansion.
Conclusions: Continued national monitoring of canine test results for vector-borne zoonotic agents is an important tool
for accurately mapping the geographic distribution of these agents, and greatly aids our understanding of the veterinary
and public health threats they pose.
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In 2009, we reported results of a national veterinary clinic
based survey of dogs in the United States for antigen to
heartworm and antibody to tick-borne disease agents [1].
Based on reported results from testing over 3 million dogs
from 2001 to 2007, this study was the first to document
and map percent positive test results on a national level to
four vector-borne disease agents, namely, Dirofilaria immi-
tis, Borrelia burgdorferi, Anaplasma spp., and Ehrlichia
spp. [1]. Dirofilaria immitis, the causative agent of heartworm* Correspondence: susan.little@okstate.edu
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unless otherwise stated.disease, is transmitted to dogs by a number of different
mosquito species and is present throughout much of the
United States [2]. Borrelia burgdorferi and Anaplasma
phagocytophilum are transmitted by Ixodes spp. ticks,
while Ehrlichia spp. are known to be vectored by Rhipice-
phalus sanguineus sensu lato as well as ticks in the genera
Amblyomma, Dermacentor, and Ixodes [3,4].
Veterinarians and pet owners are aware of these infec-
tions, and canine preventive medicine protocols commonly
include recommendations for administering routine heart-
worm prevention and tick control to dogs as well as
vaccination to prevent transmission of B. burgdorferi, the
agent of Lyme disease, in areas where transmission occurs
[5]. However, not all dogs receive adequate veterinary care,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and even when implemented, these strategies are not 100%
effective at preventing infection [2,6,7].
Because vector-borne infections can have serious impli-
cations for canine health, annual testing of dogs for these
infections is recommended and commonly performed
[2,5,8]. A number of studies have confirmed the utility of
dogs as sentinels for tick-borne diseases [9-12]. Indeed,
our original report has been widely cited and the data
repurposed by other research groups [13], and subsequent
work has shown that canine infection with some tick-
borne disease agents correlates on a state-wide basis with
reports of human disease [14]. Here, we provide an update
to our original report by summarizing the percent positive
test results of dogs tested by veterinarians in the United
States from 2010 – 2012.
Methods
Source of data
Testing results included in the 2010–2012 summary and
analysis were obtained from 5 different USDA licensed
test kits manufactured by IDEXX Laboratories, Inc:
PetChek® Heartworm PF Test, a microtiter plate ELISA
for use in-clinic or at a reference laboratory for the detec-
tion of D. immitis antigen in canine serum or plasma;
SNAP® HW RT Test kit, an in-clinic ELISA for the detec-
tion of D. immitis antigen in canine serum, plasma, or
whole blood; SNAP® 4Dx® Test kit, an in-clinic ELISA for
simultaneous detection of canine antibodies to E. canis,
B. burgdorferi and A. phagocytophilum, and to D. immitis
antigen; and SNAP® 4Dx® Plus Test kit, which was released
in 2012 to replace SNAP 4Dx and is an in-clinic ELISA
for simultaneous detection of canine antibodies to E.
canis, E. ewingii, B. burgdorferi, A. phagocytophilum, and
A. platys, and to D. immitis antigen.
Results of testing on these various test kits were ob-
tained from two primary sources: the IDEXX Reference
Laboratories network (PetChek® Heartworm PF, SNAP®
4Dx®, and SNAP® 4Dx Plus®), and those results generated
by veterinarians using all five assays and recorded in
IDEXX VetLab® Instrumentation and Software. For the
latter results, information was obtained for both results
entered manually by the clinic staff and those automatic-
ally recorded by IDEXX SnapShot Dx® instrumentation.
For reasons of privacy, patient results were obtained in
the absence of owner information or unique identifica-
tion. Because of this, it was not possible to exclude re-
peat testing events either within a practice or between
the practice and the reference laboratory.
Performance of test kits
Performance of the PetChek® Heartworm PF Test, SNAP®
HW RT Test kit, SNAP® 3Dx® Test kit, and SNAP®
4Dx® Test kit has been reported previously [1,15]. TheSNAP® 4Dx Plus® Test uses a peptide from a major outer
surface protein (p28) of E. ewingii on the Ehrlichia portion
of the test and has 96.5% sensitivity and 93.9% specificity
for the detection of E. ewingii antibodies. The Anaplasma
portion of the SNAP® 4Dx Plus® Test uses a synthetic pep-
tide from the major surface protein of A. phagocytophilum
(MSP2/p44) and has 89.1% sensitivity and 99.8% specifi-
city for the detection of A. platys antibodies [16].
Data and statistical analysis
Test results were compiled by county based on the associ-
ated postal zip code of the veterinary hospital submitting
the sample or providing the test result. Data were assem-
bled into state and regional groups as previously described
[1,17]. Four primary regional groups (Midwest, Northeast,
Southeast, and West) were considered. Percent positive
results were calculated by dividing the number of tests
reported as positive for each agent by the total number of
testing events recorded in a given county, state, or region.
For state-wide summary tables and comparison to human
disease reports, all results collected from 2010 – 2012
were included. For construction of county-based preva-
lence maps, individual counties in which fewer than 30
test results were available from a single year were ex-
cluded. Differences in the frequency of reported positive
test results between counties, states, and regions, as well
as differences in frequency of reported positive test results
in the present survey and in our earlier report [1], were
evaluated for significance with Chi-square test using SAS
(Windows 9.1) (SAS Institute Inc., Cary, NC) with signifi-
cance assigned at p < 0.0001.
Human cases of Lyme disease, ehrlichiosis, and ana-
plasmosis reported to the Centers for Disease Control
and Prevention in 2010 and 2011 [18] were adjusted to
reflect reported cases per 100,000 using average state
population data based on intercensal estimates from the
United States Census Bureau [19]; summaries of re-
ported human cases from 2012 are not yet available.
Comparison of population adjusted reports of human
disease to canine seroprevalence rates for each respect-
ive agent (B. burgdorferi, Ehrlichia spp., and Anaplasma
spp.) were performed using a linear regression and the
coefficient of determination (R2) calculated as previously
described [14]. Analyses were performed using GraphPad
Prism v.5 (GraphPad Software, La Jolla, CA).
Results
Summary
A total of 30,917,280 data points were available from
dogs tested in 1,778 counties and in all of the 50 states
in the United States over the three year period summa-
rized in the present paper (Table 1); evidence of at least
one agent was found in dogs from every state consid-
ered. Antigen to heartworm was identified in dogs in
Table 1 Percent positive test results (number positive/number tested) by region for dogs tested from 2010 – 2012
in the United States for antigen of Dirofliaria immitis and antibody to Borrelia burgdorferi, Ehrlichia spp., and
Anaplasma spp.
State Dirofilaria immitis Borrelia burgdorferi Ehrlichia spp. Anaplasma spp.
Northeast 0.4% (11,675/3,175,080) 13.3% (373,212/2,806,273) 0.9% (24,011/2,806,112) 7.1% (189,486/2,652,801)
Midwest 0.7% (20,014/2,817,915) 4.4% (76,025/1,720,510) 1.0% (17,337/1,720,168) 3.9% (59,580/1,548,686)
Southeast 2.9% (101,850/3,562,190) 2.5% (51,232/2,058,574) 3.2% (65,191/2.057,984) 0.9% (14,046/1,631,332)
West 0.8% (8,887/1,178,947) 1.4% (5,726/410,840) 1.3% (5,134/410,419) 2.0% (7,056/359,449)
Overall mean 1.3% (142,426/10,734,132) 7.2% (509,195/6,996,197) 1.6% (111,673/6,994,683) 4.4% (270,168/6,192,268)
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identified in dogs in every state except Alaska, where
test results were not available, and, for B. burgdorferi
and Ehrlichia spp., Montana. Distribution of positive
tests and relative percent positive values by county and
state are shown in Figures 1, 2, 3 and 4.
Heartworm
Percent positive test results for antigen of D. immitis were
higher in the Southeast than in the other three regions, andFigure 1 Evidence of antigen to Dirofilaria immitis in dogs by county,
received from counties shaded gray, precluding interpretation of the prese
had no dogs reported as positive (0%). Remaining counties were coded as
(dark red).were higher in the West and Midwest than in the Northeast
(Table 1). Within areas of relatively low percent positive test
results, certain counties had unexpectedly high results, in-
cluding Belknap County, New Hampshire; Summit County,
Utah; Walla Walla and Stevens Counties in Washington;
and Shasta and Trinity Counties in California (Figure 1).
Regional prevalence of percent positive test results for
D. immitis antigen was lower in each of the four regions
considered, and dramatically so in the Southeast, as com-
pared to our previous report.grouped according to percent positive tests. No results (<30) were
nce of antigen in dogs from these areas. Counties depicted in white
follows: 0.1-2.0% (light pink), 2.1-4.0% (pink), 4.1-6.0% (red), and > 6.0%
Figure 2 Evidence of antibody to Borrelia burgdorferi in dogs by county, grouped according to percent positive tests. No results (<30)
were received from counties shaded gray, precluding interpretation of the presence of antibody in dogs from these areas. Counties depicted in
white had no dogs reported as positive (0%). Remaining counties were coded as follows: 0.1-0.5% (light blue), 0.5-1.0% (blue), 1.1-5.0% (dark
blue), and > 5.0% (very dark blue).
Little et al. Parasites & Vectors 2014, 7:257 Page 4 of 9
http://www.parasitesandvectors.com/content/7/1/257Lyme disease
Percent positive test results for antibody to B. burgdorferi
were higher in the Northeast than in the other three
regions, and were higher in the Midwest than in the
Southeast or West (Table 1). Omitting Virginia and West
Virginia (9.7% and 3.5%, respectively), where Lyme borre-
liosis is known to be endemic, from the Southeast resulted
in a percent positive test result of 0.92% (15,086/1,631,
562) in the remainder of the region. Within areas of rela-
tively low percent positive test results, certain counties had
unexpectedly high results, including Pulaski and Whitley
Counties in Kentucky; Monroe County in Indiana; and
Clark, Crawford, and Lawrence Counties in Illinois
(Figure 2). Regional prevalence of percent positive test
results for B. burgdorferi antibody was higher in the
Northeast, Southeast, and Midwest, but unchanged in
the West, compared to our previous report.
Ehrlichiosis
Percent positive test results for antibody to Ehrlichia
spp. were higher in the Southeast than in the other threeregions, and were higher in the West than in the North-
east or Midwest (Table 1). Within areas of relatively low
percent positive test results, certain counties had unex-
pectedly high results, including Douglas and La Plata
Counties in Colorado; Hancock County, Maine; Clackamas
County, Oregon; Lamoille County, Vermont; and Clark
and King Counties in Washington (Figure 3). Percent
positive test results for Ehrlichia spp. antibody were higher
nationally and in every region considered compared to
our previous report.
Anaplasmosis
Percent positive test results for antibody to Anaplasma
spp. were highest in the Northeast and Midwest, and
were higher in the West than in the Southeast (Table 1).
Within areas of relatively low percent positive test
results, certain counties had unexpectedly high results,
including Jackson County, Oklahoma; Howard and Potter
Counties in Texas; and Minnehaha County, South Dakota
(Figure 4). Percent positive test results for Anaplasma
spp. antibody were lower nationally and in the Midwest
Figure 3 Evidence of antibody to Ehrlichia spp. in dogs by county, grouped according to percent positive tests. No results (<30) were
received from counties shaded gray, precluding interpretation of the presence of antibody in dogs from these areas. Counties depicted in white
had no dogs reported as positive (0%). Remaining counties were coded as follows: 0.1-0.5% (light purple), 0.5-1.0% (purple), 1.1-2.0% (dark purple),
and > 2.0% (very dark purple).
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previous report.
Comparison to human disease reports
Percent positive test results for antibodies to B. burgdorferi
in dogs and reported human cases of Lyme borreliosis by
state were positively associated (R2 = 0.701, F= 110.0), al-
though for some states reported human cases were higher
(Delaware and New Hampshire) or lower (Rhode Island and
South Dakota) than expected based on canine testing.
Percent positive test results for Ehrlichia spp. in dogs
and human case reports of ehrlichiosis by state were posi-
tively associated (R2 = 0.457, F= 34.5), although for some
states reported human cases were higher (Oklahoma,
Missouri, and Delaware) or lower (Arizona, Mississippi, and
Washington) than expected based on canine testing. Percent
positive test results for Anaplasma spp. in dogs and human
case reports of anaplasmosis by state were positively associ-
ated (R2 = 0.314, F= 18.8), although for some states reported
human cases were higher (Minnesota and Wisconsin) orlower (Connecticut and South Dakota) than expected based
on canine testing.
Discussion
Vector-borne infections are increasingly important to the
health of people and other animals worldwide [20-22]. The
data reported in the present paper update our previous
study and comprise the most comprehensive effort to date
to document the distribution and prevalence of infection
with these agents using canine samples [1]. Annual testing
for heartworm and tick-borne infections is recommended
and commonly performed by veterinarians [2,5]. We are
not able to identify individual dogs or eliminate test results
from the same dogs with the reporting system used, and
some of the results undoubtedly reflect repeated testing of
the same dogs. However, even if the results reported here
represent repeated testing of 3 – 4 million pet dogs, we
have likely documented the past or current infection status
of approximately 5% of the estimated 70 million pet dogs in
the United States, and perhaps as many as 10 – 15% [23].
Figure 4 Evidence of antibody to Anaplasma spp. in dogs by county, grouped according to percent positive tests. No results (<30) were
received from counties shaded gray, precluding interpretation of the presence of antibody in dogs from these areas. Counties depicted in white
had no dogs reported as positive (0%). Remaining counties were coded as follows: 0.1-0.5% (light green), 0.5-1.0% (green), 1.1-5.0% (dark green),
and > 5.0% (very dark green).
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1,420 counties, constituting 45.2% of the 3,144 counties
in the United States. Because dogs cluster in human
population centers, the present paper is biased towards
urban areas, an approach which may underestimate true
infection risk in some locales, particularly for tick-borne
infections. Although urban transmission patterns have
been described, the risk of tick-borne disease is generally
greater in areas of lower housing density with more sup-
portive habitat for the vector ticks, [24-27]. Moreover,
an adequate number of test results were not available
from many sparsely populated regions and thus we
cannot determine the likelihood for these infections to
be present across the entire nation.
As expected, heartworm infection was most commonly
identified in dogs in the southeastern United States al-
though the percent positive test results in this region were
lower than previously reported [1]. While we cannot fully
explain this reduction, the decrease may have been due
to differences in data capture strategies, which resultedin inclusion of a higher frequency of routine heartworm
tests in the data set. Strains of D. immitis resistant to
heartworm preventives have recently been described from
the southern United States, and veterinarians may be
responding with greater vigilance [28-30]. Repeatedly test-
ing dogs on heartworm preventive, and thus at low risk of
infection, would be expected to decrease the percent posi-
tive test results overall. However, several states in the area
of the country most affected by reports of resistance,
including Alabama, Georgia, Louisiana, and Mississippi,
actually have higher percent positive test results in the
present paper than were reported previously [1], (Table 1).
Although the national prevalence of positive tests for
heartworm in the present study was lower, the overall
geographic distribution of positive test results was simi-
lar to that described in the previous report. Within this
expected pattern, a number of counties with unexpect-
edly high percent positive test results were identified.
Some of these unexpected results can be explained by
the relatively low number (n = 30–45, data not shown)
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of dogs has been shown to result in an inaccurate im-
pression of the presence of vector-borne transmission
cycles due to translocation of infected pets [31]. In con-
trast, the counties identified with high percent positive
test results in northern California were based on testing
thousands of dogs and are consistent with our current
understanding of D. immitis prevalence in domestic dogs
and wild canids in that region [32,33].
In contrast to heartworm, percent positive results for
antibody to agents of tick-borne diseases, particularly
Lyme disease and ehrlichiosis, were higher nationally in
the present study than in the previous report [1], a find-
ing consistent with increased reports of these diseases in
people in recent years [34,35]. Increases in percent posi-
tive test results were also seen regionally with the most
striking change in the Southeast, where a nearly 1.5 fold
increase in prevalence of B. burgdorferi was seen, largely
due to increases in the percent positive test results
of dogs in the states of Virginia, West Virginia, and
Kentucky. A similar increased geographic distribution of
the risk of B. burgdorferi infection has been described
in public health reports although autochthonous trans-
mission of this infection in people appears to remain
focused in clear endemic and hyperendemic regions
[34,36].
An increase in percent positive test results to Ehrlichia
spp. was also evident in each of the four regions (Table 1).
This increase was not attributable to recent modifications
in the assay to include detection of antibodies to E. ewingii
[14,37] because it was evident in the data in 2010 and
2011 (data not shown), before any platform changes were
instituted. Moreover, the more widespread geographic
distribution parallels reports from human surveillance and
suggests the distribution of autochthonous transmission
has increased, consistent with other data documenting
continued geographic expansion of A. americanum ticks
[35,38-41]. However, we suspect infection with a novel
Ehrlichia sp. transmitted by ticks other than A. ameri-
canum are responsible for the positive test results that
continue to be identified in Minnesota and Wisconsin, as
has been previously described [1,42,43].
The percent positive test results for Anaplasma spp.
were lower overall, although higher in the Northeast, than
in the previous report, although large geographic variation
was seen within the regions considered. Reports of human
anaplasmosis cases have also increased in the Northeast
in recent years [35,44]. The foci of elevated percent
positive test results identified in dogs in western Texas
and Oklahoma are mostly likely due to R. sanguineus
transmitted infection with A. platys [14,45]. Brown dog
ticks are common in this region, remarkably tolerant of
arid conditions, and thrive during the 2011–2012 drought
in the southcentral United States [46], Little, unpubl. data.For each of the tick-borne agents, a few counties were
identified with unexpectedly high percent positive test
results given their geographic location within areas
largely considered low or non endemic for those dis-
eases. Some of these unexpected results are likely due to
the low number of test results available (<300), while
others may be due to the presence of novel agents.
While the overall pattern in the maps provided is of
great value in understanding distribution of disease, re-
sults for individual counties, particularly in areas not
likely to support autochthonous transmission based on
known vector phenology, should be interpreted with
caution [1]. In addition, some of the assays used may
detect novel agents as previously described [1,42,43]. In-
deed, infection with an Ehrlichia sp. other than E. canis,
E. chaffeensis, or E. ewingii may account for the higher
than expected percent positive test results identified
Clark and King Counties in Washington, where results
from more than 2,000 dogs were available (Figure 3).
The canine serology results for the tick-borne disease
agents in the present study largely agreed with reports of
human disease for each respective type of disease. How-
ever, the association was strongest for canine antibodies to
Borrelia burgdorferi and human Lyme disease, a finding
which is not surprising as the assay used in dogs is known
to be exquisitely specific and canine serology has been
shown previously to correspond with reports of Lyme
borreliosis in people [1,13,47]. The associations between
canine serology and reports of human ehrlichiosis and
anaplasmosis, while significant, were admittedly weak. The
assays used in the present study detect multiple Ehrlichia
spp. and Anaplasma spp., including some agents thought
unlikely to cause disease in people, such as E. canis and A.
platys, suggesting canine seroprevalence data may be of
limited value in understanding the distribution of and
transmission risk for those zoonotic agents [47-49]. Previ-
ous studies which showed strong agreement between ca-
nine seroprevalence to Ehrlichia spp. and reports of human
ehrlichiosis employed species-specific serologic assays, a
strategy which may be necessary to generate accurate pre-
dictive models for zoonotic infection risk [14]. Nonetheless,
there were geographies with discordant results for human
ehrlichiosis even using specific canine assays. This discrep-
ancy may be, in part, due to the lack of species-specific
diagnostic tools for use in human medicine when detecting
antibodies to E. chaffeensis and A. phagocytophilum [50,51].
Annual canine preventive medicine protocols include
testing for evidence of vector-borne infections in addition
to implementing preventive strategies like routine acari-
cide use and vaccination. The canine serology results
help veterinarians to assess the efficacy of the prevention
protocol for that particular patient and modify it accord-
ingly if evidence of transmission is identified [52]. By test-
ing all dogs within a practice, it is possible to gain a
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nized disease agents as well as identify the emergence of a
previously uncommon pathogen. Translocation of in-
fected dogs also occurs [1,31], complicating interpretation,
although identifying infection with disease agents outside
the range where they are known to be transmitted can be
important to the health of individual patients. Finally, by
understanding the relative importance of different vector-
borne diseases within their practice area, veterinarians
provide a public health service to the community by
educating pet owners not only on the risks for their dog
but the potential risk that these vector-borne infections
may have for public health.Conclusions
In this study, we have provided a comprehensive update
on the frequency of positive test results for the most
common vector-borne disease agents in the dog in the
United States. While the broad geographical trends
remained consistent with the previous report, several
important differences were noted. Positive test results
for D. immitis antigen were significantly lower in every
region considered, while percent positive test results for
antibodies to B. burgdorferi and Ehrlichia spp. were
higher nationally than previously reported, and anti-
bodies to Anaplasma spp. were higher in the Northeast
but lower in the Midwest and West. Canine serology
and the frequency of positive test results is an important
tool for accurately mapping the geographic distribution
of these agents. Recognizing geographic variations in
percent positive test results also raises opportunities for
future investigations on the distribution of tick species
and the risk of human tick-borne disease in both endemic
and non-endemic areas.
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